68Ga-PSMA PET/CT With Incidental Finding of COVID-19 in an Asymptomatic Patient
Authors:
- 15 October 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 45 (12) , 1032-1033
Abstract
A 70-year-old man with prostate adenocarcinoma was diagnosed by transrectal biopsy, with Gleason of 4 + 5 and initial PSA of 225 ng/mL since March 2020. 68 Ga-PSMA PET/CT was performed as part of initial staging. The images showed an enlarged prostate with focal PSMA uptake in both lobes. Retroperitoneal and pelvic lymph nodes with moderate uptake of PSMA were shown. Another finding was a moderate PSMA uptake in the both lung parenchymas associated with opacities in CT. The patient denied any symptoms of coronavirus disease and was referred to the emergency department for RT-PCR COVID-19, and the result was positive.Keywords
This publication has 8 references indexed in Scilit:
- 99mTc-Leukocyte Scintigraphy Revealed Viral Pulmonary Infection in a COVID-19 PatientClinical Nuclear Medicine, 2020
- Incidental COVID-19 Pneumonia on 18F-Fluorocholine PET/CTClinical Nuclear Medicine, 2020
- Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence RegionJournal of Nuclear Medicine, 2020
- Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findingsCancer Imaging, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Revisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of SpreadRadioGraphics, 2019
- Pitfalls in Gallium-68 PSMA PET/CT Interpretation—A Pictorial ReviewTomography, 2018
- 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2017